RAP 0.00% 20.5¢ resapp health limited

EPT , telehealth company . I'll let others to research (and wont...

  1. 722 Posts.
    lightbulb Created with Sketch. 151
    EPT , telehealth company .

    I'll let others to research (and wont spell out what it does here in this thread) but if you want refer to the announcements made in June and July 2017 the investor presentation about what it is, and the announcement in July 2017 of regulatory approval granted for Australia (TGA) and Europe (CE), along with strategic partnership with Nviso. It also had a peer reviewed study journal article published (no mean feat)

    Then refer back to Oct-2016 when it backdoor listed from MNQ for the prospectus page 33 where it states regulatory approval in Q3-2017, which it achieved in the first month of Q3!!!!.
    FDA is planned 2018.

    Also earlier investor presentations from earlier in the year described the timeline for commercialisation of the app in Q4-17 which has been re-iterated in the latest investor presentation of July-17 as still being the case, and reinforced by management communication.

    Timelines can be achieved by management in spec companies, rare but possible.
 
watchlist Created with Sketch. Add RAP (ASX) to my watchlist

Currently unlisted public company.

arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.